Longevity medicine encompasses a range of therapeutic approaches aimed at extending human lifespan by addressing the underlying biological processes associated with aging. This includes regenerative therapies to repair or replace damaged tissues and organs, gene editing technologies like CRISPR to modify genes linked to aging, and lifestyle interventions such as diet and exercise.
Age-related diseases such as Alzheimer's, cardiovascular disease, and cancer, which currently have limited treatment options and contribute significantly to the global burden of illness and healthcare costs.
CRISPR technology is used to edit specific genes that are known to play a role in the aging process. New drugs are developed targeting age-related conditions, which can be administered orally or through other means. Lifestyle interventions focus on promoting healthy living practices that support overall health and longevity.
The manufacturing process involves developing and testing new drugs in controlled laboratory settings. CRISPR gene editing requires specialized equipment and expertise for precise modifications. Lifestyle interventions are more broadly applicable but require careful design and implementation to ensure effectiveness.
Research and development involve extensive preclinical studies, animal testing, and clinical trials to validate the safety and efficacy of new treatments. Collaboration between biotech companies, academic institutions, and regulatory bodies is crucial for bringing these therapies to market.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.